Status:
COMPLETED
Effects of Moringa Oleifera Leaves on Glycemia, Lipemia and Inflammatory Profile in Prediabetic Patients
Lead Sponsor:
National Research Council, Spain
Conditions:
PreDiabetes
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
Moringa oleifera (MO) is a traditional food in tropical and subtropical areas and has attained a growing interest for its medicinal properties. It's a nutrient-rich vegetable, high in protein and poly...
Detailed Description
The tree Moringa oleifera (MO) is a traditional medicinal plant in tropical and subtropical areas, also consumed as food, which is currently expanding worldwide as a protein-rich leafy vegetable and f...
Eligibility Criteria
Inclusion
- Prediabetes: HbA1c between 5.7-6.4 % or fasting blood glucose between 100 - 125 mg/dl or impaired glucose tolerance (\> 140 mg/dl and \< 200 mg/dl two hours post oral challenge).
- No pharmacological treatment prescribed for glycemia control.
Exclusion
- Diabetes Mellitus
- Impaired renal function: \< 60% Glomerular filtration
- Uncontrolled high blood pressure
- Previous cardiovascular events or coronary disease
- Autoimmune disease
- HIV
- Severe gastrointestinal disease
- Cancer
- Psychiatric illness
- Elevated liver enzymes (x2 normal range)
- Alcohol abuse (higher than 14 and 21 doses/week for women and men, respectively)
- Morbid obesity (BMI\>35kg/m2)
- Pregnancy
- Pharmacological treatments that interfere with glucose control.
Key Trial Info
Start Date :
January 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 26 2021
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04734132
Start Date
January 22 2019
End Date
January 26 2021
Last Update
February 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Food Science and Technology and Nutrition (ICTAN)-CSIC
Madrid, Spain, 28040